|
Office Locations:
|
303 Wyman Street, Suite 300
Waltham, MA 02451
Phone: 781-472-2743
Fax: 781-472-2642
| |
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
LSP is one of Europe's largest and most experienced healthcare investment firms. The firm has raised more than EURO2 billion through various funds that target drug development and medical technology. Currently LSP manages three different fund types: LSP 6, a closed-end private equity fund investing in early-to late stage drug development and medical technology companies; LSP HEF 2 (Health Economic Fund), a closed-end private equity fund investing in late-stage medical technology companies with a health and economic benefit; and LSP Public, an open-ended fund investing in healthcare companies listed on a stock exchange. The fund itself is listed on Euronext as LSP Life Sciences Fund with ticker LSP NA and ISIN Code NL0009756394.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
COMPANY STAGE | REVENUE |
Venture Capital | |
Seed Stage (includes "pre-seed," or concept stage) | No Revenue |
Early Stage | Minimal Revenue |
Growth Stage (also called Mid-stage) | $2M-$7M |
Expansion Stage (also called Late-stage) | $7M and greater |
Private Equity | |
Lower Middle Market | $10M-$249M |
Middle Market | $250M-$499M |
Upper Middle Market | $500M-$1B |
Large Cap | >$1B |
|
|
|
|